Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Said

Showing results (81-90 of 126) with videos related to

Pageof 13
Sort By:
Molecular Carcinogenesis|March 12, 2013
Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivoWenwen Chien, Dhong Hyun Lee, Yun Zheng, et al.
Plos One|August 13, 2013
Levels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line, 2F7Daniel P Widney, Tove Olafsen, Anna M Wu, et al.
The Journal of Urology|May 19, 2010
Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinomaTobias Klatte, Mesut Remzi, Richard E Zigeuner, et al.
Cancer|October 1, 2008
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapiesArie S Belldegrun, Tobias Klatte, Brian Shuch, et al.
AIDS Research and Treatment|April 15, 2011
Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaDaniel P Widney, Dorina Gui, Laura M Popoviciu, et al.
The Journal of Urology|October 22, 2011
The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinomaDavid S Finley, Brian Shuch, Jonathan W Said, et al.
Cancer|May 10, 2005
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinomaJohn S Lam, Oleg Shvarts, Jonathan W Said, et al.
Molecular Cancer Therapeutics|May 8, 2012
Effect of a low-fat diet combined with IGF-1 receptor blockade on 22Rv1 prostate cancer xenograftsRamdev Konijeti, Satomi Koyama, Ashley Gray, et al.
Cancer Research|July 17, 2009
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cellsNils H Thoennissen, Gabriela B Iwanski, Ngan B Doan, et al.
International Journal of Cancer|March 18, 2004
Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarraysKunihiro Tsukasaki, Sakae Tanosaki, Sven DeVos, et al.
Pageof 13

Showing results (81-90 of 126) with videos related to

Sort By:
Pageof 13
Molecular Carcinogenesis|March 12, 2013
Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivoWenwen Chien, Dhong Hyun Lee, Yun Zheng, et al.
Plos One|August 13, 2013
Levels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line, 2F7Daniel P Widney, Tove Olafsen, Anna M Wu, et al.
The Journal of Urology|May 19, 2010
Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinomaTobias Klatte, Mesut Remzi, Richard E Zigeuner, et al.
Cancer|October 1, 2008
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapiesArie S Belldegrun, Tobias Klatte, Brian Shuch, et al.
AIDS Research and Treatment|April 15, 2011
Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaDaniel P Widney, Dorina Gui, Laura M Popoviciu, et al.
The Journal of Urology|October 22, 2011
The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinomaDavid S Finley, Brian Shuch, Jonathan W Said, et al.
Cancer|May 10, 2005
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinomaJohn S Lam, Oleg Shvarts, Jonathan W Said, et al.
Molecular Cancer Therapeutics|May 8, 2012
Effect of a low-fat diet combined with IGF-1 receptor blockade on 22Rv1 prostate cancer xenograftsRamdev Konijeti, Satomi Koyama, Ashley Gray, et al.
Cancer Research|July 17, 2009
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cellsNils H Thoennissen, Gabriela B Iwanski, Ngan B Doan, et al.
International Journal of Cancer|March 18, 2004
Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarraysKunihiro Tsukasaki, Sakae Tanosaki, Sven DeVos, et al.
Pageof 13